{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:01:58Z","timestamp":1777395718604,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.clinbiochem.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T10:31:23Z","timestamp":1568457083000},"page":"42-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy"],"prefix":"10.1016","volume":"74","author":[{"given":"Osman","family":"Evliyaoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"van Helden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Jaruschewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Im\u00f6hl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0005","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/clinchem\/40.11.2154","article-title":"The monoclonal gammopathies","volume":"40","author":"Kyle","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0010","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0015","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.beha.2007.08.001","article-title":"Epidemiology of the plasma-cell disorders","volume":"20","author":"Kyle","year":"2007","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International myeloma working group. International myeloma working group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0030","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1515\/cclm-2015-0689","article-title":"New patterns of relapse in multiple myeloma: a case of \"light chain escape\" in which FLC predicted relapse earlier than urine and serum immunofixation","volume":"54","author":"Caldini","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"issue":"11","key":"10.1016\/j.clinbiochem.2019.09.004_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41408-018-0144-x","article-title":"Evolving changes in M-protein and hemoglobin as predictors for progression of smoldering multiple myeloma","volume":"8","author":"Atrash","year":"2018","journal-title":"Blood Cancer J."},{"issue":"12","key":"10.1016\/j.clinbiochem.2019.09.004_bb0040","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2013.08.018","article-title":"Serum free light chains in clinical laboratory diagnostics","volume":"427","author":"Jenner","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1515\/cclm-2015-0580","article-title":"Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias","volume":"54","author":"Willrich","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0055","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International myeloma working group. International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0060","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1373\/clinchem.2009.124461","article-title":"Quantitation of serum monoclonal proteins: relationship between agarose gel electrophoresis and immunonephelometry","volume":"55","author":"Murray","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0065","unstructured":"International Myeloma Foundation. International Myeloma Working Group (IMWG) criteria for the diagnosis of multiple myeloma. Available at: https:\/\/www.myeloma.org\/international-myeloma-working-group-imwg-criteria-diagnosis-multiple-myeloma. (Last accessed: 9 August 2019)."},{"issue":"6","key":"10.1016\/j.clinbiochem.2019.09.004_bb0070","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1038\/bcj.2017.46","article-title":"Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma","volume":"7","author":"Ravi","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jcp.2007.047175","article-title":"What is a significant difference between sequential laboratory results?","volume":"61","author":"Smellie","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0080","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1373\/clinchem.2011.171314","article-title":"Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies","volume":"57","author":"Katzmann","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clinbiochem.2017.10.006","article-title":"Monoclonal protein reference change value as determined by gel-based serum protein electrophoresis","volume":"51","author":"Salamatmanesh","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0090","doi-asserted-by":"crossref","first-page":"507","DOI":"10.5858\/arpa.2017-0128-CP","article-title":"Screening and diagnosis of monoclonal gammopathies: an international survey of laboratory practice","volume":"142","author":"Genzen","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/ajcp\/110.4.503","article-title":"Prospective study of serum protein capillary zone electrophoresis and immunotyping of monoclonal proteins by immunosubtraction","volume":"110","author":"Katzmann","year":"1998","journal-title":"Am. J. Clin. Pathol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2019.09.004_bb0100","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1038\/bcj.2016.65","article-title":"Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma","volume":"6","author":"Ravi","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10408368909106595","article-title":"Generation and application of data on biological variation in clinical chemistry","volume":"27","author":"Fraser","year":"1989","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"8","key":"10.1016\/j.clinbiochem.2019.09.004_bb0110","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0115","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41375-018-0339-y","article-title":"Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements","volume":"33","author":"Dejoie","year":"2019","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.09.004_bb0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12882-018-0962-x","article-title":"Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma","volume":"19","author":"Yadav","year":"2018","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0130","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004","volume":"79","author":"Gertz","year":"2005","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clinbiochem.2019.09.004_bb0140","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0004563213518758","article-title":"Serum-free light-chain assay: clinical utility and limitations","volume":"51","author":"Bhole","year":"2014","journal-title":"Ann. Clin. Biochem."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019305454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019305454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:54:24Z","timestamp":1757865264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912019305454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":28,"alternative-id":["S0009912019305454"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.09.004","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}